Somatus
Somatus provides integrated kidney care, combining local clinical teams with RenalIQ, a proprietary machine-learning platform that identifies patients at risk of kidney failure. It contracts with health plans, health systems, and nephrology and primary care groups under value-based arrangements. It raised a Series E of more than $325M in February 2022 at a valuation reported as unicorn-level (about $3.6B), and bought AI assets from Lumiata in 2022. In July 2025 it reported more than 500,000 patients under management across all 50 states and DC, with 100+ nephrology practices as partners.
Funding
Every round, secondary, debt facility or acquisition involving Somatus that AI Lounge tracks, newest first.
No rounds recorded yet.
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in